Please login to the form below

Not currently logged in
Email:
Password:

vaccines

This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.

Sanofi to buy acne specialist Origimm

Sanofi to buy acne specialist Origimm

Its first therapeutic vaccine candidate, ORI-001, based on recombinant proteins, entered preliminary clinical studies for acne vulgaris earlier this year. ... The acquisition of Origimm further broadens our vaccines R&D pipeline with a first vaccine

Latest news

  • US regulators set to approve oral antiviral against COVID-19 US regulators set to approve oral antiviral against COVID-19

    In the light of the new variant of concern, Omicron, yet to be detected in the USA, the need for treatments for COVID-19 as well as preventative vaccines is climbing.

  • Booster plans expanded to combat Omicron Booster plans expanded to combat Omicron

    Now, all adults 18 and over are eligible, with the waiting time after the second dose of the primary vaccine course reduced from six to three months. ... Plans are also being formulated for boosters to be recognised in vaccine certificates.

  • COVID-19 vaccines against Omicron may be fast-tracked COVID-19 vaccines against Omicron may be fast-tracked

    Regulators including the Food and Drug Administration (FDA) may treat Omicron-specific mRNA vaccines like seasonal flu vaccines, speeding up approval. ... BioNTech CEO Uğur Şahin has been talking about the similarities he sees between tweaked COVID-19

  • Omicron prompts global action Omicron prompts global action

    fact that 30 of the 50 new mutations are on the all-important spike protein, the target of most vaccines. ... Vaccine maker BioNTech said: “We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529.

  • First trial of a vaccine against Alzheimer’s launches First trial of a vaccine against Alzheimer’s launches

    Researchers in the US hope that the vaccine can stimulate the brain’s immune system to clear the amyloid plaques seen in Alzheimer’s. ... Protollin has been used safely in humans as an adjuvant for other vaccines.

More from news
Approximately 187 fully matching, plus 1,434 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 134 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 84 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...